A Phase 1, Randomized, Double-blind, Placebo-controlled Dosage Escalation Trial to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted in HIV-uninfected, Healthy Adult Volunteers
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008695/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a phase 1 first-in-human clinical trial to assess the safety, tolerability, and
immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted, in up to 48 healthy adult HIV-negative
volunteers.
提供机构：
Vivli
创建时间：
2022-12-22
